The Rising Influence of Rising Affluence

[DewDiligence]

I expect GILD will be paid something if the drug works and is eventually approved by the FDA for COVID-19 treatment; however, when all is said and done GILD’s return on investment will either be zero, negative, or way below the typical threshold for undertaking a pharmaceutical project.